SLC34A2 promotes cell proliferation by activating STX17 ‐mediated autophagy in esophageal squamous cell carcinoma
Thoracic Cancer · 2024
DOI: 10.1111/1759-7714.15314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, 2024. Verfasst von Yi Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Autophagy, Cell Proliferation, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Solute carrier family 34 member 2 (SLC34A2) has been implicated in the development of various malignancies. However, the clinical significance and underlying molecular mechanisms of SLC34A2 in esophageal squamous cell carcinoma (ESCC) remain elusive.
Methods
Western blotting, quantitative real‐time PCR and immunohistochemistry were utilized to evaluate the expression levels of SLC34A2 mRNA/protein in ESCC cell lines or tissues. Kaplan–Meier curves were employed for survival analysis. CCK‐8, colony formation, EdU and xenograft tumor model assays were conducted to determine the impact of SLC34A2 on ESCC cell proliferation. Cell cycle was examined using flow cytometry. RNA‐sequencing and enrichment analysis were carried out to explore the potential signaling pathways. The autophagic flux was evaluated by western blotting, mRFP‐GFP‐LC3 reporter system and transmission electron microscopy. Immunoprecipitation and mass spectrometry were utilized for identification of potential SLC34A2‐interacting proteins. Cycloheximide (CHX) chase and ubiquitination assays were conducted to test the protein stability.
Results
The expression of SLC34A2 was significantly upregulated in ESCC and correlated with unfavorable clinicopathologic characteristics particularly the Ki‐67 labeling index and poor prognosis of ESCC patients. Overexpression of SLC34A2 promoted ESCC cell proliferation, while silencing SLC34A2 had the opposite effect. Moreover, SLC34A2 induced autophagy to promote ESCC cell proliferation, whereas inhibition of autophagy suppressed the proliferation of ESCC cells. Further studies showed that SLC34A2 interacted with an autophagy‐related protein STX17 to promote autophagy and proliferation of ESCC cells by inhibiting the ubiquitination and degradation of STX17.
Conclusions
These findings indicate that SLC34A2 may serve as a prognostic biomarker for ESCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
- Department of Radiation Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Sheng Ye
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, Y., Duan, S., Ye, W., Zheng, Z., Zhang, J., Gao, Y., & Ye, S. (2024). SLC34A2 promotes cell proliferation by activating STX17 ‐mediated autophagy in esophageal squamous cell carcinoma. Thoracic Cancer. https://doi.org/10.1111/1759-7714.15314
Vancouver
Xu Y, Duan S, Ye W, Zheng Z, Zhang J, Gao Y, et al. SLC34A2 promotes cell proliferation by activating STX17 ‐mediated autophagy in esophageal squamous cell carcinoma. Thoracic Cancer. 2024. doi:10.1111/1759-7714.15314
BibTeX
@article{Xu2024,
author = {Xu, Yi and Duan, Shiyu and Ye, Wen and Zheng, Zhousan and Zhang, Jiaxing and Gao, Ying and Ye, Sheng},
title = {SLC34A2 promotes cell proliferation by activating STX17 ‐mediated autophagy in esophageal squamous cell carcinoma},
journal = {Thoracic Cancer},
year = {2024},
doi = {10.1111/1759-7714.15314}
}
EUVIMED